Patient Guide: Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05266807
Status: 🟢 Enrolling Now
Condition: Clostridioides Difficile Infection
Phase: PHASE3

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Basel, Basel
  • • Bern, Canton of Bern
  • • Fribourg, Canton of Fribourg
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence - Join Clinical Trial NCTNCT05266807

How to Join This Clinical Trial - NCTNCT05266807

Learn how to participate in this PHASE3 trial studying an investigational therapy for Clostridioides Difficile Infection. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Clostridioides Difficile Infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Clostridioides Difficile Infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05266807 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Basel, Basel 4031 - Switzerland

Status: RECRUITING

Clinical Research Site

Bern, Canton of Bern 3010 - Switzerland

Status: RECRUITING

Clinical Research Site

Fribourg, Canton of Fribourg 1708 - Switzerland

Status: RECRUITING

Clinical Research Site

Sankt Gallen, Canton of St. Gallen 9007 - Switzerland

Status: RECRUITING

Clinical Research Site

Lausanne, Canton of Vaud 1011 - Switzerland

Status: RECRUITING

Clinical Research Site

Zurich, Canton of Zurich 8091 - Switzerland

Status: RECRUITING

Clinical Research Site

Sion, Valais 1950 - Switzerland

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Clostridioides Difficile Infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships